Recombinant hymenoptera venom allergens

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 7, 2002, Pages 570-576

  Muller U R ^a  

^a Medical Division   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; HYMENOPTERA VENOM; PHOSPHOLIPASE A2; RECOMBINANT PROTEIN;

ALLERGIC REACTION; B LYMPHOCYTE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HONEYBEE; HUMAN; IMMUNOTHERAPY; INTRACUTANEOUS TEST; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; REVIEW;

ALLERGENS; ANIMALS; HUMANS; HYMENOPTERA; HYPERSENSITIVITY, IMMEDIATE; RECOMBINANT PROTEINS; VENOMS;

EID: 0036095653     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.02157.x     Document Type: Review

References (45)

1. A revised nomenclature for allergy
2. The sting challenge test in Hymenoptera venom allergy
3. Immunotherapy with honey bee venom and yellow jacket venom is different regarding efficacy and safety
4. Structure and biology of stinging insect venom allergens
5. cDNA cloning and primary structure of a white-face hornet venom allergen, antigen 5
6. 1 with mammalian lipases
7. Yellow jacket venom allergens, hyaluronidase and phospholipase. Sequence similarity and antigenic crossreactivity with their hornet and wasp homologs and possible implications for clinical allergy
8. Expressions of recombinant venom allergen, antigen 5 of yellow jacket (Vespula vulgaris) and paper wasp (Polistes annularis) in bacteria or yeast
9. Purification and immunobiochemical characterization of folding variants of the recombinant major wasp allergen Ves v 5 (antigen 5)
10. 2 from honey bee venom glands. The deduced amino acid sequence reveals homology to the corresponding vertebrate enzymes
11. 2
12. Bee venom hyaluronidase is homologous to a membrane protein of mammalian sperm
13. Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli
14. Molecular cloning of a new honey bee venom allergen, acid phosphatase
15. Crystal structure of bee venom phospholipase A2 in a complex with a transition-state analogue
16. Crystal structure of hyaluronidase, a major allergen of bee venom
17. The structure of melittin II. Interpretation of the structure
18. 2 from honey bee venom is similar
19. Rekombinantes bienengift-allergen phospholipase A2
20. Fucose: A 1 3-linked to the core region of glycoprotein N-glycans creates an important epitope for IgE from honey bee venom allergic individuals
21. Carbohydrate dependant, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients
22. Clinical relevance of carbohydrate allergen epitopes
23. 2 has the same potency to release histamine from basophils in patients with Hymenoptera allergy
24. The purification of hyaluronidase from the venom of the honey bee (Apis mellifera)
25. Biological activity of glycosylation and active site mutants of honey bee venom hyaluronidase
26. Sequence identity and antigenic crossreactivity of white face hornet venom allergen, also a hyaluronidase, with other proteins
27. Sequence analysis and antigen crossreactivity of a venom allergen antigen 5 from hornets, wasps and yellow jackets
28. Yellow jacket allergens, hyaluronidase and phospholipase. Sequence similarity and antigenic crossreactivity with their hornet and wasp homologs and possible implications for clinical allergy
29. Structural analysis and mapping of IgE epitopes on vespid allergen Ves v 5
30. Production of a recombinant imported fire ant venom allergen, Sol i 2, in native and immunoreactive form
31. Expression of recombinant fire ant venom protein Sol i 3
32. Allergens in Hymenoptera venoms XXIV. The amino acid sequences of imported fire ant venom allergens Sol i 2, Sol i 3 and Sol i 4
33. Molecular cloning and characterization of a major allergen Myr p 1 from the venom of the Australian jumper ant, Myrmecia pilosula
34. Hyaluronidases - A group of neglected enzymes
35. 2
36. Bee venom allergy. Comparison of IgE-binding capacity of purified natural and recombinant-synthetic venom allergens
37. The recombinant allergen-based concept of component resolved diagnostics and immunotherapy
38. Immunotherapy with T-cell reactive peptides derived from allergens
39. T cell epitope specificity in human allergic and non allergic subjects to bee venom phospholipase A2
40. Mapping human T-cell epitopes on phospholipase A2: The major bee venom allergen
41. Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: Interest for specific immunotherapy
42. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
43. Treatment of cat allergy with T-cell reactive peptides
44. Epitope specific T-cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-5 in vitro